The critical role of vascular endothelial growth factor (VEGF) expression levels in developmental angiogenesis is well established. Nonetheless, the effects of different local (microenvironmental) VEGF concentrations in ischemia have not been studied in the adult organism, and VEGF delivery to patients has been disappointing. Here, we demonstrate the existence of both lower and upper threshold levels of microenvironmental VEGF concentrations for the induction of therapeutic vessel growth in ischemia. In the ischemic hind limb, implantation of myoblasts transduced to express VEGF164 at different levels per cell increased blood flow only moderately, and vascular leakage and aberrant preangiomatous vessels were always induced. When the same total dose was uniformly distributed by implanting a monoclonal population derived from a single VEGF-expressing myoblast, blood flow was fully restored to nonischemic levels, collateral growth was induced, and ischemic damage was prevented. Hemangiomas were avoided and only normal, pericyte-covered vessels were induced persisting over 15 mo. Surprisingly, clones uniformly expressing either lower or higher VEGF levels failed to provide any functional benefit. A biphasic effect of VEGF dose on vessel number and diameter was found. Blood flow was only improved if vessels were increased both in size and in number. Microenvironmental VEGF concentrations determine efficacy and safety in a therapeutic setting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1096/fj.06-6568fje | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Revamping anti-cGAS-STING therapy via an injectable thermo-responsive supramolecular hydrogel for pathological retinal angiogenesis.
Asian J Pharm Sci
October 2024
Xiamen University affiliated Xiamen Eye Center; Fujian Provincial Key Laboratory of Ophthalmology and Visual Science; Fujian Engineering and Research Center of Eye Regenerative Medicine; Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen 361100, China.
Retinal neovascularization is a leading cause of blindness. While current anti-VEGF drugs effectively inhibit pathological angiogenesis, some patients develop resistance or reduced responsiveness to treatments over time, leading to diminished effectiveness. In this study, we identified high activation of the cGAS-STING signaling pathway, which exacerbated pathological neovascularization and vessel leakage.
View Article and Find Full Text PDFAMBER: A Modular Model for Tumor Growth, Vasculature and Radiation Response.
Bull Math Biol
October 2024
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Article Synopsis
- Computational models of tumor growth, especially agent-based models (ABMs), help simulate cancer progression and treatment responses, but often lack realism due to limited domains and missing factors like blood vessels.
- AMBER (Agent-based fraMework for radioBiological Effects in Radiotherapy) overcomes these shortcomings by using a voxelized geometry for realistic simulations, integrating microenvironmental factors and combining ABM techniques with advanced radiation dose calculations from the Monte Carlo method.
- The results from AMBER provide accurate predictions of tumor evolution and radiation outcomes, making it a valuable tool for studying tumor growth and treatment responses with the potential for future enhancements.
PAIP1 binds to pre-mRNA and regulates alternative splicing of cancer pathway genes including VEGFA.
BMC Genomics
October 2024
First department of infection, second affiliated hospital of Harbin medical university, 246 Xuefu Road, Harbin, 150000, Heilongjiang, China.
Background: Poly (A) binding protein interacting protein 1 (PAIP1) has been shown to causally contribute to the development and progression of cancer. However, the mechanisms of the PAIP1 regulation in tumor cells remain poorly understood.
Results: Here, we used a recently developed UV cross-linking and RNA immunoprecipitation method (iRIP-seq) to map the direct and indirect interaction sites between PAIP1 and RNA on a transcriptome-wide level in HeLa cells.
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.
Mol Cancer
September 2024
Department of Medicine, Institut Bergonié, 229 cours de l'Argonne, Bordeaux, 33000, France.
Anti-angiogenic agents elicit considerable immune modulatory effects within the tumor microenvironment, underscoring the rationale for synergistic clinical development of VEGF and immune checkpoint inhibitors in advanced gastric cancer (AGC). Early phase studies involving Asian patients demonstrated encouraging anti-tumor efficacies. We report the results of the REGOMUNE phase II study, in which Caucasian patients were administered regorafenib, a multi-tyrosine kinase inhibitor, in combination with avelumab, a PD-L1-targeting monoclonal antibody.
View Article and Find Full Text PDFCancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-Dependent Microenvironmental Remodeling to Support Colorectal Cancer.
Cancer Res
October 2024
Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Tumor stroma plays a critical role in fostering tumor progression and metastasis. Cancer-associated fibroblasts (CAF) are a major component of the tumor stroma. Identifying the key molecular determinants for the protumor properties of CAFs could enable the development of more effective treatment strategies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!